Growth Metrics

Solid Biosciences (SLDB) Other Working Capital Changes (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Other Working Capital Changes for 8 consecutive years, with -$414000.0 as the latest value for Q4 2024.

  • Quarterly Other Working Capital Changes fell 178.71% to -$414000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2024, up 401.51% year-over-year, with the annual reading at $8.0 million for FY2025, 576.91% up from the prior year.
  • Other Working Capital Changes hit -$414000.0 in Q4 2024 for Solid Biosciences, down from $41659.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $7.6 million in Q4 2021 to a low of -$7.5 million in Q3 2022.
  • Historically, Other Working Capital Changes has averaged $116122.0 across 5 years, with a median of $41659.0 in 2024.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 435.77% in 2021 and later crashed 431.59% in 2022.
  • Year by year, Other Working Capital Changes stood at $1.4 million in 2020, then surged by 435.77% to $7.6 million in 2021, then tumbled by 198.5% to -$7.5 million in 2022, then skyrocketed by 107.02% to $526000.0 in 2023, then crashed by 178.71% to -$414000.0 in 2024.
  • Business Quant data shows Other Working Capital Changes for SLDB at -$414000.0 in Q4 2024, $41659.0 in Q3 2024, and $41659.0 in Q2 2024.